Hsbc Holdings PLC Has $53.27 Million Stock Holdings in Tenet Healthcare Corporation $THC

Hsbc Holdings PLC raised its position in Tenet Healthcare Corporation (NYSE:THC) by 3,478.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 266,400 shares of the company’s stock after acquiring an additional 258,956 shares during the period. Hsbc Holdings PLC owned about 0.31% of Tenet Healthcare worth $53,269,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of THC. Norges Bank acquired a new position in shares of Tenet Healthcare in the fourth quarter valued at $248,494,000. Eminence Capital LP bought a new stake in Tenet Healthcare in the 3rd quarter valued at $225,263,000. Wellington Management Group LLP raised its stake in shares of Tenet Healthcare by 1,114.2% in the 4th quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company’s stock valued at $225,706,000 after buying an additional 1,042,260 shares in the last quarter. Boston Partners boosted its position in shares of Tenet Healthcare by 38.8% during the 3rd quarter. Boston Partners now owns 3,147,555 shares of the company’s stock valued at $638,958,000 after acquiring an additional 880,413 shares in the last quarter. Finally, AQR Capital Management LLC increased its stake in Tenet Healthcare by 62.3% in the third quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after acquiring an additional 720,160 shares during the period. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Price Performance

THC opened at $180.74 on Wednesday. The stock has a market capitalization of $15.57 billion, a P/E ratio of 9.40, a price-to-earnings-growth ratio of 1.47 and a beta of 1.28. Tenet Healthcare Corporation has a one year low of $146.60 and a one year high of $247.21. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. The company’s 50 day simple moving average is $181.69 and its 200-day simple moving average is $197.96.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. During the same quarter in the prior year, the firm posted $4.36 earnings per share. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Sell-side analysts anticipate that Tenet Healthcare Corporation will post 17.61 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have commented on THC. Wells Fargo & Company cut their price target on shares of Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. KeyCorp dropped their target price on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Morgan Stanley set a $254.00 price target on Tenet Healthcare in a research report on Friday, May 1st. Mizuho lifted their price objective on Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a report on Thursday, March 12th. Finally, Guggenheim reduced their target price on shares of Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Eighteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, Tenet Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $244.32.

Insider Buying and Selling at Tenet Healthcare

In related news, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the transaction, the director owned 24,805 shares of the company’s stock, valued at $4,399,166.75. This trade represents a 10.79% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total transaction of $983,943.76. Following the completion of the sale, the director owned 16,804 shares in the company, valued at approximately $2,932,634.08. This trade represents a 25.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.97% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.